Literature DB >> 1576054

Human and mouse liver coumarin 7-hydroxylases do not metabolize warfarin in vitro.

P Honkakoski1, P Arvela, R Juvonen, M A Lang, M Kairaluoma, O Pelkonen.   

Abstract

1. The contribution of human P450 2A6 and mouse P450 2a-5 isoenzymes, both highly active in coumarin 7-hydroxylation, to the metabolism of warfarin was studied in several in vitro systems with human and mouse liver preparations. 2. The reconstituted P450 2a-5 purified from DBA/2 mouse liver did not metabolize warfarin. 3. An anti-P450 2a-5 antibody did not consistently inhibit any of the warfarin biotransformation reactions catalyzed by human or mouse liver microsomes, although coumarin 7-hydroxylation was inhibited by over 90%. 4. In some human microsomal samples, 4- and 8-hydroxylations of warfarin were inhibited to some extent by the anti-P450 2a-5 antibody. 5. Warfarin (less than 1 mM) did not inhibit coumarin 7-hydroxylation by human or mouse liver microsomes in vitro. 6. We conclude that mouse and human coumarin 7-hydroxylases do not oxidise warfarin.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1576054      PMCID: PMC1381282          DOI: 10.1111/j.1365-2125.1992.tb04042.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  18 in total

1.  High coumarin 7-hydroxylase activity does not protect mice against Warfarin.

Authors:  I E Lush; C J Arnold
Journal:  Heredity (Edinb)       Date:  1975-10       Impact factor: 3.821

2.  Characteristics of warfarin hydroxylation catalyzed by human liver microsomes.

Authors:  A E Rettie; A C Eddy; L D Heimark; M Gibaldi; W F Trager
Journal:  Drug Metab Dispos       Date:  1989 May-Jun       Impact factor: 3.922

3.  Purification and characterization of a liver microsomal cytochrome P-450 isoenzyme with a high affinity and metabolic capacity for coumarin from pyrazole-treated D2 mice.

Authors:  R O Juvonen; V M Shkumatov; M A Lang
Journal:  Eur J Biochem       Date:  1988-01-15

Review 4.  Aspects of anticoagulant action: a review of the pharmacology, metabolism and toxicology of warfarin and congeners.

Authors:  F A Sutcliffe; A D MacNicoll; G G Gibson
Journal:  Rev Drug Metab Drug Interact       Date:  1987

5.  Mouse liver P450Coh: genetic regulation of the pyrazole-inducible enzyme and comparison with other P450 isoenzymes.

Authors:  M A Lang; R Juvonen; P Järvinen; P Honkakoski; H Raunio
Journal:  Arch Biochem Biophys       Date:  1989-05-15       Impact factor: 4.013

6.  Immunochemical and catalytical studies on hepatic coumarin 7-hydroxylase in man, rat, and mouse.

Authors:  H Raunio; T Syngelmä; M Pasanen; R Juvonen; P Honkakoski; M A Kairaluoma; E Sotaniemi; M A Lang; O Pelkonen
Journal:  Biochem Pharmacol       Date:  1988-10-15       Impact factor: 5.858

7.  Coumarin 7-hydroxylase activity in human liver microsomes. Properties of the enzyme and interspecies comparisons.

Authors:  O Pelkonen; E A Sotaniemi; J T Ahokas
Journal:  Br J Clin Pharmacol       Date:  1985-01       Impact factor: 4.335

8.  Identification of the human liver cytochrome P-450 responsible for coumarin 7-hydroxylase activity.

Authors:  J S Miles; A W McLaren; L M Forrester; M J Glancey; M A Lang; C R Wolf
Journal:  Biochem J       Date:  1990-04-15       Impact factor: 3.857

9.  Induction of liver cytochrome P-450 in mice by warfarin. Comparison of warfarin-, phenobarbitone-, and cobalt-induced hepatic microsomal protein patterns by PAGE after partial purification on octyl-sepharose CL-4B.

Authors:  L Kling; W Legrum; K J Netter
Journal:  Biochem Pharmacol       Date:  1985-01-01       Impact factor: 5.858

Review 10.  The P450 superfamily: update on new sequences, gene mapping, and recommended nomenclature.

Authors:  D W Nebert; D R Nelson; M J Coon; R W Estabrook; R Feyereisen; Y Fujii-Kuriyama; F J Gonzalez; F P Guengerich; I C Gunsalus; E F Johnson
Journal:  DNA Cell Biol       Date:  1991 Jan-Feb       Impact factor: 3.311

View more
  1 in total

1.  Effect of tanshinone IIA on the noncovalent interaction between warfarin and human serum albumin studied by electrospray ionization mass spectrometry.

Authors:  Jie Liu; Xiaoru Wang; Zongwei Cai; Frank S C Lee
Journal:  J Am Soc Mass Spectrom       Date:  2008-06-28       Impact factor: 3.109

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.